RAB13: A Protein Involved in Cell Signaling Pathways and Cancer Development

Target Name: RAB13

NCBI ID: G5872

RAB13

RAB13: A Protein Involved in Cell Signaling Pathways and Cancer Development

RAB13 (RAB13, member RAS oncogene family) is a protein that is expressed in various tissues throughout the body, including the heart, lungs, liver, and brain. It is a member of the RAS oncogene family, which is a group of proteins that are known to play a role in the development and progression of many diseases, including cancer.

One of the key functions of RAB13 is its role in the regulation of cell signaling pathways. Specifically, it is involved in the RAS/MAPK signaling pathway, which is a critical pathway that regulates many cellular processes, including cell growth, differentiation, and survival.

The RAS/MAPK signaling pathway is a complex system that is composed of several proteins, including RAB13. This pathway is activated when the RAS protein is phosphorylated, which causes it to enter the active state and then translocate to the MAPK2 protein, which then phosphorylates other proteins in the pathway, leading to a cascade of signaling events.

RAB13 is known to play a key role in the regulation of this pathway, as it is a critical protein that is involved in the formation of the RAS/MAPK complex. This complex is formed when the RAS protein is phosphorylated and then translocates to the MAPK2 protein, where it interacts with a protein called SMAD1. This interaction between RAB13 and SMAD1 is critical for the formation of the RAS/MAPK complex and for the regulation of the MAPK signaling pathway.

In addition to its role in the RAS/MAPK signaling pathway, RAB13 is also involved in the regulation of many other cellular processes, including cell adhesion, migration, and survival. For example, RAB13 has been shown to be involved in the regulation of tight junction formation in epithelial cells, which is important for maintaining tissue structure and barrier function.

RAB13 is also involved in the regulation of many signaling pathways that are important for cellular processes, including cell proliferation, differentiation, and apoptosis. For example, it has been shown to play a role in the regulation of the PI3K/AKT signaling pathway, which is involved in the regulation of cellular metabolism and energy homeostasis.

In addition to its role in cellular signaling pathways, RAB13 is also considered a potential drug target or biomarker. Several studies have shown that inhibiting RAB13 can have a variety of therapeutic effects, including the inhibition of cancer cell growth, the inhibition of cell migration, and the inhibition of cell survival.

One of the potential mechanisms by which RAB13 may be targeted by drugs is its role in the regulation of cell signaling pathways. By inhibiting the activity of RAB13, drugs can potentially disrupt the regulation of cellular processes and lead to the development of cancer.

Another potential mechanism by which RAB13 may be targeted by drugs is its role in the regulation of cell adhesion and migration. By inhibiting the activity of RAB13, drugs can potentially disrupt the regulation of cell-cell adhesion and cell migration, leading to the development of tissues that are less organized and more prone to cancer.

In addition to its potential therapeutic effects, RAB13 is also a potential biomarker for the diagnosis and prognosis of many diseases. For example, studies have shown that the expression of RAB13 is often elevated in tissues of cancer, and that it can be used as a biomarker for the diagnosis and prognosis of cancer.

Overall, RAB13 is a protein that is involved in the regulation of many cellular processes, including cell signaling pathways, cell adhesion,

Protein Name: RAB13, Member RAS Oncogene Family

Functions: The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes. Rabs cycle between an inactive GDP-bound form and an active GTP-bound form that is able to recruit to membranes different sets of downstream effectors directly responsible for vesicle formation, movement, tethering and fusion. That Rab is involved in endocytic recycling and regulates the transport to the plasma membrane of transmembrane proteins like the tight junction protein OCLN/occludin. Thereby, it regulates the assembly and the activity of tight junctions. Moreover, it may also regulate tight junction assembly by activating the PKA signaling pathway and by reorganizing the actin cytoskeleton through the activation of the downstream effectors PRKACA and MICALL2 respectively. Through its role in tight junction assembly, may play a role in the establishment of Sertoli cell barrier. Plays also a role in angiogenesis through regulation of endothelial cells chemotaxis. Also involved in neurite outgrowth. Has also been proposed to play a role in post-Golgi membrane trafficking from the TGN to the recycling endosome. Finally, it has been involved in insulin-induced transport to the plasma membrane of the glucose transporter GLUT4 and therefore may play a role in glucose homeostasis

The "RAB13 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RAB13 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets